Pharmacological aspects of human and canine narcolepsy (Q34740875)

4 August 2017

1 reference

title

Pharmacological aspects of human and canine narcolepsy (English)

1 reference

4 August 2017

0 references

1 reference

Nishino S

1

1 reference

4 August 2017

Mignot E

series ordinal

2

1 reference

4 August 2017

language of work or name

1 reference

1 May 1997

1 reference

4 August 2017

published in

Progress in Neurobiology

1 reference

4 August 2017

volume

52

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

27-78

1 reference

Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Mono-amine oxidase inhibitors, sleep and mood

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The clinical spectrum of narcolepsy and idiopathic hypersomnia

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Automobile accidents in patients with sleep disorders

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The neurobiology of narcolepsy-cataplexy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Narcolepsy associated with lesions of the diencephalon

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Exacerbation of human cataplexy by prazosin.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The Clinical Use of the Multiple Sleep Latency Test

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Regularly occurring periods of eye motility, and concomitant phenomena, during sleep

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effects of imipramine, chlorimipramine, and fluoxetine on cataplexy in dogs

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The carbachol-induced enhancement of desynchronized sleep signs is dose dependent and antagonized by centrally administered atropine.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Canine model of narcolepsy: genetic and developmental determinants.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Treatment of Narcolepsy with Mono-Amino-Oxidase Inhibitors and Sympathomimetic Agents

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

[The effects of modafinil (300mg) on sleep, sleepiness and arousal in narcoleptic patients].

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Narcolepsy: cholinergic receptor changes in an animal model

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effects of bromocriptine on periodic limb movements in human narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The effects of L-dopa on excessive daytime sleepiness in narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effects of bromocriptine in human narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effects of modafinil on symptomatology of human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Brain dopamine receptor levels elevated in canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Evidence for the existence of a homogeneous population of imidazoline receptors in the human brainstem

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched controls

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Life effects of narcolepsy: relationships to geographic origin (North American, Asian or European) and to other patient and illness variables.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: a laboratory perspective.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Psychosocial impact of narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Forty-eight-hour polysomnographic evaluation of narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Sleepiness after glucose in narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Breastfeeding and the use of psychotropic medication: a review

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Narcolepsy in children

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

[3H]Nisoxetine binding sites in the cat brain: an autoradiographic study

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The atonia and myoclonia of active (REM) sleep

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The dopamine transporter: immunochemical characterization and localization in brain

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Treatment of narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Diflunisal-induced maternal anemia as a cause of teratogenicity in rabbits

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

REM sleep suppression induced by selective monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

1 reference

7 January 2021

Cholinergic mechanisms and cataplexy in dogs

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The nature of the narcoleptic sleep attack

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Evidence for dopamine receptors mediating sedation in the mouse brain

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Magnocellular nuclei of the basal forebrain project to neocortex, brain stem, and olfactory bulb. Review of some functional correlates

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

5-HT1-like receptor agonists enhance wakefulness

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Trial with amantadine in narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Monoaminergic mechanisms and experimental cataplexy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Treatment of narcolepsy with codeine

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Electroencephalographic analyses of amphetamine and its methoxy derivatives with reference to their sites of EEG alerting in the rabbit brain

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

High prevalence of isolated sleep paralysis: kanashibari phenomenon in Japan

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin—comparison of fluoxetine and chlorimipramine

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The pedunculopontine nucleus.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Stability of cataplexy over several months--information for the design of therapeutic trials.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

[Diagnosis of narcolepsy-cataplexy: importance of continuous recording in ambulatory EEG. Report of 20 cases]

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

A CHOLINERGIC MECHANISM IN THE BRAINSTEM RETICULAR FORMATION: INDUCTION OF PARADOXICAL SLEEP.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Tranylcypromine in narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Deprenyl as symptomatic therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

1 reference

7 January 2021

Altered states of consciousness in disorders of daytime sleepiness

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

235 cases of excessive daytime sleepiness. Diagnosis and tentative classification

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Viloxazine hydrochloride in narcolepsy: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Prazosin contraindicated in patients with narcolepsy.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Controversies in the diagnosis of narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

1 reference

7 January 2021

The Urinary Output of Catecholamines in Narcolepsy Under Resting Conditions and Following Administration of Dopamine, Dopa, and Dops

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Preliminary clinical trial with L-DOPA in narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Bright white light does not improve narcoleptic symptoms

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Gelineau's narcolepsy relieved by opiates

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Daytime sleepiness and daytime wakefulness: the effect of instruction.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effects of protriptyline on vigilance and information processing in narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Treatment of narcolepsy with imipramine (tofranil) and desmethylimipramine (pertofran)

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The nature of sleep attack and other symptoms of narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Sleep satiation in narcoleptic patients

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Acetylcholine as a brain state modulator: triggering and long-term regulation of REM sleep.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Treatment of narcolepsy-cataplexy syndrome with the new selective and reversible MAO-A inhibitor brofaromine-a pilot study

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Sleepiness and performance in narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Selegiline in the treatment of narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Epidemiology of narcolepsy.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology?

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effects of L-tyrosine on mixed-acting sympathomimetic-induced pressor actions

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Therapeutic effects of mazindol on narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Acetylcholine liberation from cerebral cortex during paradoxical (REM) sleep

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Paradoxical sleep and its chemical/structural substrates in the brain

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Retrograde labeling of neurones in the brain stem following injections of [3H]choline into the forebrain of the rat.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Evidence for excessive sleepiness in canine narcoleptics

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effects of thalidomide and pentobarbital on neuronal activity in the preoptic area during sleep and wakefulness in the cat.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Successful treatment of narcolepsy with propranolol: a case report

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Narcolepsy-cataplexy. I. Clinical and electrophysiologic characteristics

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Thalidomide, immune modulation and narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Ergotamine Tartrate in the Treatment of Narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Cytokine regulation of disease progression in leprosy and tuberculosis

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

A pharmacological model of paradoxical sleep: The role of cholinergic and monoamine systems

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Muscarinic cholinergic receptors and the canine model of narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Enhancement of acetylcholine release during paradoxical sleep in the dorsal tegmental field of the cat brain stem

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Fluoxetine for isolated sleep paralysis

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Neurotransmitter receptors and ionic conductances regulating the activity of neurones in substantia nigra pars compacta and ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Modafinil in diurnal sleepiness. A study of 123 patients.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The Multiple Sleep Latency Test: a paradoxical test?

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Fluoxetine in the treatment of cataplexy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Antidepressant and circadian phase-shifting effects of light

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Sleep cycle organization in narcoleptic and normal dogs

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Baseline sleep-wake patterns in the pointer dog

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat laterodorsal tegmental nucleus in vitro

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

DQ (rather than DR) gene marks susceptibility to narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Selegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Motor dyscontrol in sleep of narcoleptic patients (a lifelong development?).

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Neuronal excitability modulation over the sleep cycle: a structural and mathematical model

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Clinical pharmacology of monoamine oxidase inhibitors.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Distribution of norepinephrine, epinephrine, dopamine, serotonin, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindole-3-acetic acid in dog brain

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Propranolol: long-term treatment in narcolepsy-cataplexy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6).

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Central alpha 1 adrenoceptor subtypes in narcolepsy-cataplexy: a disorder of REM sleep

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effect of alpha 1-adrenoceptors blockade with prazosin in canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Role of central alpha-1 adrenoceptors in canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Central administration of yohimbine increases free 3-methoxy-4-hydroxyphenylglycol in the cerebrospinal fluid of the rat

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Modafinil binds to the dopamine uptake carrier site with low affinity.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Narcolepsy and immunity

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Narcolepsy-cataplexy in a female dog

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Cataplectic-like behavior in cats after micro-injections of carbachol in pontine reticular formation

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Evaluation of treatment with stimulants in narcolepsy.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Sleep studies on canine narcolepsy: pattern and cycle comparisons between affected and normal dogs

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Maintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Relative Efficacy of Drugs for the Treatment of Sleepiness in Narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

1 reference

7 January 2021

Catecholamines and the sleep-wake cycle. I. EEG and behavioral arousal

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Serotoninergic reuptake mechanisms in the control of cataplexy.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Venlafaxine: A Structurally Unique and Novel Antidepressant

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The positive diagnosis of narcolepsy and narcolepsy's borderland

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Nocturnal REM latency and sleep disturbance in narcolepsy.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Treatment of narcolepsy with L-tyrosine

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Dopaminergic transmission and the sleep-wakefulness continuum in man.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Excitatory action of TRH on spinal motoneurones

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Dopamine D2 mechanisms in canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Ventral root depolarization and spinal reflex augmentation by a TRH analog in rat spinal cord

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

A PROPOSED MECHANISM OF EMOTION

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Natural history, symptoms and treatment of the narcoleptic syndrome

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Amphetamine prescription

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Levo(-) amphetamine and dextro( ) amphetamine in the treatment of narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Cataplexy relieved by tiapride

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Psychiatric morbidity in narcoleptics on chronic high dose methylphenidate therapy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Pontine lesions in idiopathic narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Eating and its relationships with subjective alertness and sleep in narcoleptic subjects living without temporal cues

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Excretion of psychoactive drugs into breast milk. Pharmacokinetic principles and recommendations

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

EFFECT OF PHENELZINE AND SOME RELATED COMPOUNDS ON PREGNANCY AND ON SEXUAL DEVELOPMENT

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effects of thyrotropin-releasing hormone in depression

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

γ‐Hydroxybutyrate in narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

NOCTURNAL SLEEP OF NARCOLEPTICS

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Cholinergic mechanisms in canine narcolepsy--II. Acetylcholine release in the pontine reticular formation is enhanced during cataplexy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Cholinergic mechanisms in canine narcolepsy--I. Modulation of cataplexy via local drug administration into the pontine reticular formation

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Deprenyl is metabolized to methamphetamine and amphetamine in man

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Electrophysiological Studies of the Functions of the Nucleus Basalis in Primates

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Problems and coping strategies identified by narcoleptic patients

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Compliance with stimulant medications in patients with narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Patterns of sleep and wakefulness in treated narcoleptic subjects.

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The latency of activation of neurones in the lateral hypothalamus and substantia innominata during feeding in the monkey

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

HLA DR2 in narcolepsy with sleep-onset REM periods but not cataplexy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Signs and symptoms associated with cataplexy in narcolepsy patients

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Interactions between reserpine and various compounds on the accumulation of [14C] 5-hydroxytryptamine and [3H]noradrenaline in homogenates from rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

REM sleep and NREM sleep in narcolepsy and hypersomnia

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Histological and ultrastructural evidence that D-amphetamine causes degeneration in neostriatum and frontal cortex of rats

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Efficacy of trazodone in narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Nomifensine exacerbates narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Fluvoxamine and clomipramine in the treatment of cataplexy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Deprenyl in narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Protriptyline: an effective agent in the treatment of the narcolepsy- cataplexy syndrome and hypersomnia

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effects of several centrally active drugs on the sleep-wakefulness cycle of cats

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Narcolepsy, Paranoid Psychosis, Major Depression, and Tardive Dyskinesia

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The treatment of accessory symptoms in narcolepsy: a double-blind cross-over study of a selective serotonin re-uptake inhibitor (femoxetine) versus placebo

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Treatment of Cataplexy With Clomipramine

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The ascending cholinergic reticular system: neocortical, olfactory and subcortical projections

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effect of the thyrotropin-releasing hormone analogue on an electrographic picture of sleep

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Activity of medial mesopontine units during cataplexy and sleep-waking states in the narcoleptic dog

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The role of the raphe nuclei in the regulation of ponto-geniculo-occipital wave activity

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The effect of behavioral stimulant doses of amphetamine on blood pressure

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Induction and Resetting of REM Sleep Rhythm in Normal Man by Arecholine: Blockade by Scopolamine

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

REM Sleep Induction by Physostigmine Infusion During Sleep

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

NARCOLEPSY AND OTHER DISTURBANCES IN THE SLEEP-WAKING RHYTHM: A STUDY OF 115 CASES WITH REVIEW OF THE LITERATURE

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Response of dopaminergic neurons in cat to auditory stimuli presented across the sleep-waking cycle

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Physiological sleep tendency and ability to maintain alertness at night

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Sleep onset rapid-eye-movement episodes in narcolepsy: REM sleep pressure or nonREM-REM sleep dysregulation?

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

1 reference

7 January 2021

Short-Term Triazolam Use Improves Nocturnal Sleep of Narcoleptics

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Simultaneous recording of substantia nigra neurons and voltammetric release of dopamine in the caudate of behaving cats

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Raphe unit activity in freely moving cats: Correlation with level of behavioral arousal

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Effect of specific M1, M2 muscarinic receptor agonists on REM sleep generation

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

The physiological (EEG) nature of drowsiness and its relation to performance deficits in narcoleptics

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Carbamazepine as a treatment for cataplexy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Studies in psychophysiology of dreams. III. The dream of narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

A new animal model of endogenous depression: a summary of present findings

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Tricyclic dose requirements across pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Cholinergic and non-cholinergic projections from the rat basal forebrain revealed by combined choline acetyltransferase and Phaseolus vulgaris leucoagglutinin immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Improvement of sleep quality by melatonin

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Treatment of intractable narcolepsy with a monoamine oxidase inhibitor

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Methysergide in the Treatment of Narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

Treatment of narcolepsy with ritalin

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

1 reference

7 January 2021

Acute mood improvement after dextroamphetamine and methylphenidate in narcolepsy

1 reference

https://api.crossref.org/works/10.1016/S0301-0082(96)50070-6

7 January 2021

10.1016/S0301-0082(96)00070-6

Identifiers

DOI

1 reference

4 August 2017

1 reference